Clinical Trial Update: Efficacy and Safety of Pseudomonas Aeruginosa for Intermediate and High-risk Non-muscle Invasive Bladder Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating efficacy and safety of Pseudomonas aeruginosa for intermediate and high-risk non-muscle invasive bladder cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Pseudomonas aeruginosa (Pseudomonas aeruginosa)

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Bladder Cancer | Phase 2 | Status: UNKNOWN